Encompass Health (EHC) concentration risks

The company's disclosed concentration profile is geographic and structural in character. Operations span hospitals in 39 states and Puerto Rico, with notable concentrations in Florida and Texas. By disclosed size this is a medium-share exposure — material enough to flag but not so dominant as to define the entire revenue base — and it reflects where the acute rehabilitation hospital network has built its densest presence over time rather than dependence on any single customer or counterparty. Because the filing singles out states rather than individual facilities, tenants, or payers, the geographic exposure is diffuse within those markets. The principal channels through which Florida and Texas concentration could affect results are state-level Medicaid policy, local labor markets, regional population growth and aging demographics, and state-specific certificate-of-need regulations — all of which tend to shift gradually rather than abruptly. There is no disclosed customer, product, or supplier concentration layered on top of the geographic tilt. On balance, the profile is narrow: a single geographic concentration of moderate share in two large, growing Sun Belt states. This is unlikely on its own to move the investment verdict materially, though it does argue for monitoring state Medicaid reimbursement trends and healthcare workforce conditions in Florida and Texas.

For the engine’s reasoning on EHC’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.